Phanicare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 15-06-2024
- Paid Up Capital ₹ 3.30 Cr
as on 15-06-2024
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.61 Cr
as on 15-06-2024
- Satisfied Charges ₹ 12.66 Cr
as on 15-06-2024
- Revenue 55.11%
(FY 2023)
- Profit 34.24%
(FY 2023)
- Ebitda 29.86%
(FY 2023)
- Net Worth 28.09%
(FY 2023)
- Total Assets 26.63%
(FY 2023)
About Phanicare Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.30 Cr.
The company currently has active open charges totaling ₹16.61 Cr. The company has closed loans amounting to ₹12.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mallikarjuna Venati, Padma Duvvuri, Vishnuvardhan Devireddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG2003PTC041815
- Company No.
041815
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Oct 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Shaikpet, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Phanicare Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mallikarjuna Venati  | Director | 08-Apr-2015 | Current |
| Padma Duvvuri | Director | 21-Apr-2016 | Current |
| Vishnuvardhan Devireddy | Director | 08-Apr-2015 | Current |
| Sumanth Karlapudi | Director | 01-Oct-2022 | Current |
Financial Performance of Phanicare Pharmaceuticals.
Phanicare Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.11% increase. The company also saw a substantial improvement in profitability, with a 34.24% increase in profit. The company's net worth Soared by an impressive increase of 28.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phanicare Pharmaceuticals?
In 2023, Phanicare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Konar Organics LimitedActive 36 years 11 monthsMallikarjuna Venati, Padma Duvvuri and 1 more are mutual person
Popular Molecules Private LimitedActive 9 years 6 monthsMallikarjuna Venati and Vishnuvardhan Devireddy are mutual person
- Norrish Laboratories Private LimitedActive 12 years 28 days
Mallikarjuna Venati, Padma Duvvuri and 2 more are mutual person
- Hps Laboratories Private LimitedActive 18 years 9 months
Mallikarjuna Venati, Padma Duvvuri and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 30 Sep 2023 | ₹3.50 Cr | Open |
Axis Bank Limited Creation Date: 01 Jul 2020 | ₹1.61 Cr | Open |
Axis Bank Limited Creation Date: 04 Oct 2018 | ₹11.50 Cr | Open |
How Many Employees Work at Phanicare Pharmaceuticals?
Phanicare Pharmaceuticals has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phanicare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phanicare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
